BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6118084)

  • 1. Efforts to limit the size of myocardial infarcts.
    Rude RE; Muller JE; Braunwald E
    Ann Intern Med; 1981 Dec; 95(6):736-61. PubMed ID: 6118084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can infarct size be limited in patients with acute myocardial infarction?
    Muller JE; Braunwald E
    Cardiovasc Clin; 1983; 13(1):147-61. PubMed ID: 6129059
    [No Abstract]   [Full Text] [Related]  

  • 3. Infarct size reduction: a review of the clinical trials.
    Campbell CA; Przyklenk K; Kloner RA
    J Clin Pharmacol; 1986; 26(5):317-29. PubMed ID: 2871053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of ischemic myocardium in experimental animals and in man: a review.
    Bolli R
    Cardiovasc Res Cent Bull; 1982; 21(1):1-33. PubMed ID: 6127160
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of myocardial infarct size by early intervention.
    Danner SA
    Neth J Med; 1977; 20(3):107-15. PubMed ID: 18687
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prospects for the limitation of the size of acute myocardial infarction].
    Boland J; Legrand V
    Rev Med Liege; 1983 Dec; 38(24):915-26. PubMed ID: 6142514
    [No Abstract]   [Full Text] [Related]  

  • 7. A rationale for therapy of acute myocardial infarction: limitation of infarct size.
    Gillespie TA; Sobel BE
    Adv Intern Med; 1977; 22():319-53. PubMed ID: 14484
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitation of myocardial infarct size. Present status.
    Yusuf S; Sleight P
    Drugs; 1983 May; 25(5):441-50. PubMed ID: 6134608
    [No Abstract]   [Full Text] [Related]  

  • 9. Interventions that potentially limit myocardial infarct size: overview of clinical trials.
    Yusuf S
    Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of myocardial infarct in the acute phase].
    Trigano JA; Torresani J; Jouve A
    Rev Prat; 1974 Dec 7-11; 24(55):5019-20, 5023-4, 5029-30 passim. PubMed ID: 4155526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protection for the ischemic myocardium: a transition between the experimental laboratory and medical practice].
    da Luz PL; Leite JJ; de Barros LF; Pileggi F
    Arq Bras Cardiol; 1980 Mar; 34(3):237-52. PubMed ID: 6108100
    [No Abstract]   [Full Text] [Related]  

  • 12. Early intervention in acute myocardial infarction: one center's perspective.
    Sobel BE
    Am J Cardiol; 1984 Dec; 54(11):2E-7E. PubMed ID: 6150633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size--can it be measured or modified in humans?
    Buja LM; Willerson JT
    Prog Cardiovasc Dis; 1987; 29(4):271-89. PubMed ID: 2880366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of conventional management and alternative therapies in limiting infarct size in acute myocardial infarction.
    Misinski M
    Heart Lung; 1987 Nov; 16(6 Pt 2):746-55. PubMed ID: 2890604
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent aspects on basic drug therapy of acute myocardial infarct].
    Erbel R; Belz GG
    Med Klin; 1977 Sep; 72(35):1341-60. PubMed ID: 20560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Review: Assessment of some therapeutic measures in acute myocardial infarction (author's transl)].
    Wang ZH
    Zhonghua Nei Ke Za Zhi; 1980 Mar; 19(2):140-7. PubMed ID: 6110522
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats.
    Barletta MA; Staab R; Lau Cam C; Lynch VD
    J Pharm Sci; 1978 Nov; 67(11):1643-5. PubMed ID: 712614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
    Opie LH
    Am Heart J; 1980 Oct; 100(4):531-52. PubMed ID: 6106384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)].
    Zannad F; Gilgenkrantz JM; Royer RJ
    Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.